Learn more about the next steps for a copper compound shown to halt progression of ALS in mice.
Scoop.it!
No comment yet.
Sign up to comment
Research and publish the best content.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Already have an account: Login
#ALS AWARENESS #LouGehrigsDisease #PARKINSONS
158.1K views |
+0 today
Raising ALS | Lou Gehrigs Disease & Parkinsons Disease AWARENESS to the NEXT LEVEL!
 Your new post is loading...
Your new post is loading...
Scoop.it!
Scoop.it!
With help from the ALS Association, NEALS provides up-to-date information for finding both federally and privately funded clinical studies focusing on ALS and motor neuron diseases. You can locate both interventional trials, which examine if treatments are effective and safe under controlled environments, and observation trials, which examine people in more natural environments.
Scoop.it!
With help from the ALS Association, NEALS provides up-to-date information for finding both federally and privately funded clinical studies focusing on ALS and motor neuron diseases. You can locate both interventional trials, which examine if treatments are effective and safe under controlled environments, and observation trials, which examine people in more natural environments.
Scoop.it!
Seth Christensen's friends and family are joining together to raise money so that he can join an important ALS clinical trial in Utah.
Scoop.it!
When Amicus Therapeutics’ (NASDAQ: ]) stock tanked a few months ago following a regulatory delay for its lead drug, CEO John Crowley promised there would b
Scoop.it!
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that patient screening will commence in connection with Questcor's Phase 2 Study to explore the safety and tolerability of H.P. Acthar® Gel (repository corticotropin injection) in patients with Amyotrophic Lateral Sclerosis (ALS). ALS -- often referred to as Lou Gehrig's disease -- is a progressive, degenerative disease affecting motor neurons. ALS is a serious debilitating disease that significantly alters one's quality of life. According to the ALS Association, the average life expectancy from the time of diagnosis for someone affected by this disorder is about two to five years. The study will seek to enroll up to 40 patients in an 8-week randomized, open-label trial designed to.................................
|
Scoop.it!
Scoop.it!
Marijuana-based treatments could delay the progression of a fatal condition known as Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS).
Scoop.it!
New delivery methods of levodopa are in clinical testing. Quicker absorption and better maintenance of therapeutic levels will mean less "off" periods for people living with Parkinson’s disease.
Scoop.it!
Just three months after receiving a receiving a $1 million grant from the Michael J. Fox Foundation, Civitas Therapeutics Wednesday said it landed $38 million in Series B financing.
Scoop.it!
A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials and observational studies. ClinicalTrials.gov includes both interventional and observational studies. Visit: ClinicalTrials.gov
Scoop.it!
Fox Trail Finder is a user friendly matching tool that connects volunteers with the PD clinical trials that need them.
Scoop.it!
Brainstorm is running a Phase I/II clinical trial with NurOwn™ ,BrainStorm’s autologous stem cell therapy for people with Amyotrophic Lateral Sclerosis (ALS often referred to as Lou Gehrig's Disease).
|
